Progress in tetanus prophylaxis: the advent of human antitoxin
Injections of tetanus antitoxin of animal origin frequently cause serious disability and sometimes death. Despite world-wide knowledge of these effects, millions of prophylactic injections of equine tetanus antitoxin are given annually, and it is continually proposed that the dosage be increased in...
Gespeichert in:
Veröffentlicht in: | Canadian Medical Association journal 1966-02, Vol.94 (9), p.437-441 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 441 |
---|---|
container_issue | 9 |
container_start_page | 437 |
container_title | Canadian Medical Association journal |
container_volume | 94 |
creator | Perey, B J |
description | Injections of tetanus antitoxin of animal origin frequently cause serious disability and sometimes death. Despite world-wide knowledge of these effects, millions of prophylactic injections of equine tetanus antitoxin are given annually, and it is continually proposed that the dosage be increased in order to obtain higher "protective" levels in the serum, a procedure which would increase the incidence and severity of reactions. Furthermore, equine antitoxin frequently fails to prevent tetanus.Tetanus antitoxin of human origin is available which carries no risk of complications and confers a higher degree of immunity more quickly than equine antitoxin. The cost of treating reactions to horse serum, together with the financial loss incurred by work-absence, far outweighs the cost of human antitoxin. In the author's opinion, the use, in this country, of antitoxin of animal origin is no longer medically acceptable and may well prove legally indefensible. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1935316</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>84080720</sourcerecordid><originalsourceid>FETCH-LOGICAL-p261t-baaff094db14029db2815b3ed50edac5bc4992a1b11b15476a6e78a2cbf189963</originalsourceid><addsrcrecordid>eNpVkE1LAzEQhnNQaq3-BCEnbwuTbPYjHgpS1AoFPeg5THaz3chusm6ypf33ViyiMPAe5uV5hjkjcwAoEyFAXpDLED4AeMpBzMgsk8ALyOdk-Tr67WhCoNbRaCK6KdBh9EN76HBvwx2NraFY74yL1De0nXp0FF200e-tuyLnDXbBXJ9yQd4fH95W62Tz8vS8ut8kA89ZTDRi04AUtWYCuKw1L1mmU1NnYGqsMl0JKTkyzY6TiSLH3BQl8ko3rJQyTxdk-cMdJt2bujpeM2KnhtH2OB6UR6v-b5xt1dbvFJNplrJvwO0JMPrPyYSoehsq03XojJ-CKgWUUHA4Fm_-mn4Vp4-lX0VKaIA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>84080720</pqid></control><display><type>article</type><title>Progress in tetanus prophylaxis: the advent of human antitoxin</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Perey, B J</creator><creatorcontrib>Perey, B J</creatorcontrib><description>Injections of tetanus antitoxin of animal origin frequently cause serious disability and sometimes death. Despite world-wide knowledge of these effects, millions of prophylactic injections of equine tetanus antitoxin are given annually, and it is continually proposed that the dosage be increased in order to obtain higher "protective" levels in the serum, a procedure which would increase the incidence and severity of reactions. Furthermore, equine antitoxin frequently fails to prevent tetanus.Tetanus antitoxin of human origin is available which carries no risk of complications and confers a higher degree of immunity more quickly than equine antitoxin. The cost of treating reactions to horse serum, together with the financial loss incurred by work-absence, far outweighs the cost of human antitoxin. In the author's opinion, the use, in this country, of antitoxin of animal origin is no longer medically acceptable and may well prove legally indefensible.</description><identifier>ISSN: 0008-4409</identifier><identifier>PMID: 5902706</identifier><language>eng</language><publisher>Canada</publisher><subject>Animals ; Antitoxins - adverse effects ; Current Progress ; Humans ; Oxytetracycline - therapeutic use ; Tetanus - prevention & control ; Tetanus Antitoxin - therapeutic use</subject><ispartof>Canadian Medical Association journal, 1966-02, Vol.94 (9), p.437-441</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1935316/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1935316/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/5902706$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Perey, B J</creatorcontrib><title>Progress in tetanus prophylaxis: the advent of human antitoxin</title><title>Canadian Medical Association journal</title><addtitle>Can Med Assoc J</addtitle><description>Injections of tetanus antitoxin of animal origin frequently cause serious disability and sometimes death. Despite world-wide knowledge of these effects, millions of prophylactic injections of equine tetanus antitoxin are given annually, and it is continually proposed that the dosage be increased in order to obtain higher "protective" levels in the serum, a procedure which would increase the incidence and severity of reactions. Furthermore, equine antitoxin frequently fails to prevent tetanus.Tetanus antitoxin of human origin is available which carries no risk of complications and confers a higher degree of immunity more quickly than equine antitoxin. The cost of treating reactions to horse serum, together with the financial loss incurred by work-absence, far outweighs the cost of human antitoxin. In the author's opinion, the use, in this country, of antitoxin of animal origin is no longer medically acceptable and may well prove legally indefensible.</description><subject>Animals</subject><subject>Antitoxins - adverse effects</subject><subject>Current Progress</subject><subject>Humans</subject><subject>Oxytetracycline - therapeutic use</subject><subject>Tetanus - prevention & control</subject><subject>Tetanus Antitoxin - therapeutic use</subject><issn>0008-4409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1966</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkE1LAzEQhnNQaq3-BCEnbwuTbPYjHgpS1AoFPeg5THaz3chusm6ypf33ViyiMPAe5uV5hjkjcwAoEyFAXpDLED4AeMpBzMgsk8ALyOdk-Tr67WhCoNbRaCK6KdBh9EN76HBvwx2NraFY74yL1De0nXp0FF200e-tuyLnDXbBXJ9yQd4fH95W62Tz8vS8ut8kA89ZTDRi04AUtWYCuKw1L1mmU1NnYGqsMl0JKTkyzY6TiSLH3BQl8ko3rJQyTxdk-cMdJt2bujpeM2KnhtH2OB6UR6v-b5xt1dbvFJNplrJvwO0JMPrPyYSoehsq03XojJ-CKgWUUHA4Fm_-mn4Vp4-lX0VKaIA</recordid><startdate>19660226</startdate><enddate>19660226</enddate><creator>Perey, B J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19660226</creationdate><title>Progress in tetanus prophylaxis: the advent of human antitoxin</title><author>Perey, B J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p261t-baaff094db14029db2815b3ed50edac5bc4992a1b11b15476a6e78a2cbf189963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1966</creationdate><topic>Animals</topic><topic>Antitoxins - adverse effects</topic><topic>Current Progress</topic><topic>Humans</topic><topic>Oxytetracycline - therapeutic use</topic><topic>Tetanus - prevention & control</topic><topic>Tetanus Antitoxin - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Perey, B J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Canadian Medical Association journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Perey, B J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Progress in tetanus prophylaxis: the advent of human antitoxin</atitle><jtitle>Canadian Medical Association journal</jtitle><addtitle>Can Med Assoc J</addtitle><date>1966-02-26</date><risdate>1966</risdate><volume>94</volume><issue>9</issue><spage>437</spage><epage>441</epage><pages>437-441</pages><issn>0008-4409</issn><abstract>Injections of tetanus antitoxin of animal origin frequently cause serious disability and sometimes death. Despite world-wide knowledge of these effects, millions of prophylactic injections of equine tetanus antitoxin are given annually, and it is continually proposed that the dosage be increased in order to obtain higher "protective" levels in the serum, a procedure which would increase the incidence and severity of reactions. Furthermore, equine antitoxin frequently fails to prevent tetanus.Tetanus antitoxin of human origin is available which carries no risk of complications and confers a higher degree of immunity more quickly than equine antitoxin. The cost of treating reactions to horse serum, together with the financial loss incurred by work-absence, far outweighs the cost of human antitoxin. In the author's opinion, the use, in this country, of antitoxin of animal origin is no longer medically acceptable and may well prove legally indefensible.</abstract><cop>Canada</cop><pmid>5902706</pmid><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-4409 |
ispartof | Canadian Medical Association journal, 1966-02, Vol.94 (9), p.437-441 |
issn | 0008-4409 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1935316 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Animals Antitoxins - adverse effects Current Progress Humans Oxytetracycline - therapeutic use Tetanus - prevention & control Tetanus Antitoxin - therapeutic use |
title | Progress in tetanus prophylaxis: the advent of human antitoxin |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T21%3A41%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Progress%20in%20tetanus%20prophylaxis:%20the%20advent%20of%20human%20antitoxin&rft.jtitle=Canadian%20Medical%20Association%20journal&rft.au=Perey,%20B%20J&rft.date=1966-02-26&rft.volume=94&rft.issue=9&rft.spage=437&rft.epage=441&rft.pages=437-441&rft.issn=0008-4409&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E84080720%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=84080720&rft_id=info:pmid/5902706&rfr_iscdi=true |